Citations

Showing 10 of 108083 citations.

Ultrasensitive US Microvessel Imaging of Hepatic Microcirculation in the Cirrhotic Rat Liver
Zhang, Wei , Huang, Chengwu , Yin, Tinghui , Miao, Xiaoyan , Deng, Huan , Zheng, Rongqin , Ren, Jie , Chen, Shigao , Huang, Chengwu

Mayo Clinic

Radiology | November 22, 2022 | Volume: 307 | Issue: 1 | Pages: No page available

10.1148/radiol.220739 | PMID 36413130 Get It

Young Adult Pain Rehabilitation: Interdisciplinary Development and Preliminary Outcomes of a Novel Treatment Program
Morrison, Eleshia J. P. , Tsai-Owens, Michele S, Luedtke, Connie A. , Eickhoff, Andrea, Evans, Michele M., Oetjen, Laurel A, Johannsen, Amanda L, Schiebel, Cindy J, Boyum, Kirsti K, Reynolds, Andrea L, Dresher, Emily R, Ellingson, Andrea M, Harrison, Tracy E. , Rohe, Daniel E. , Gilliam, Wesley P. , Loukianova, Larissa L., Harbeck‐Weber, Cynthia , Morrison, Eleshia J , Oetjen, Laurel , Ellingson, Andrea, Harbeck‐Weber, Cynthia

Mayo Clinic

Pain Medicine | November 22, 2022 | Volume: 24 | Issue: 6 | Pages: 593-601

10.1093/pm/pnac172 | PMID 36413072 Get It

Abstract Background Young adults with chronic pain and symptoms experience disruptions to their social, emotional, physical, and vocational functioning. Interdisciplinary pain rehabilitation programs for pediatric and adult populations are not designed specifically to address the developmental needs of young adults. Methods This article describes the development of a novel intensive interdisciplinary outpatient rehabilitation program tailored to the unique needs of young adults with chronic pain and symptoms. Tailored content included vocational assessment and consultation, financial literacy education, and sexual health education. Results Outcome data demonstrate treatment gains, with reductions in pain interference, pain severity, pain catastrophizing, and depressive symptoms, as well as improvements in mental and physical quality of life, perceived performance, perceived satisfaction with performance, and objective measures of physical functioning. Conclusions The article concludes with clinical recommendations for the management of chronic pain and symptoms in young adults, applicable across multiple treatment settings.
Non-Neoplastic Disorders of the Endocrine System
Gill, Anthony J. , Erickson, Lori A. , Fuchs, Talia L.

Mayo Clinic

No container title available | November 22, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.55418/9781933477251 Get It

In endocrine pathology, surgical pathologists often concentrate on neoplasms at the expense of non-neoplastic disease processes. This is unfortunate as non-neoplastic endocrine disorders are many times more common in the population. As in all fields of medicine, non-neoplastic endocrine diseases can closely mimic the neoplastic; an awareness of all aspects of pathology underpins routine clinical practice. This 5th Series Fascicle offers pathologists and clinicians an opportunity to develop an increased understanding of nontumor endocrine pathology in order to inform patient care.
Sarcopenia identified by computed tomography imaging using a deep learning–based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma
Nandakumar, Bharat , Abdallah, Nadine , Kumar, Shaji , Dingli, David , Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Fonder, Amie , Hobbs, Miriam, Hwa, Yi L. , Warsame, Rahma , Kourelis, Taxiarchis , Kyle, Robert A. , Klug, Jason, Korfiatis, Panagiotis , Baffour, Francis , Abdallah, Nadine H , Kumar, Shaji K , Hwa, Yi Lisa, Kourelis, Taxiarchis V, Dingli, David , Dispenzieri, Angela , Buadi, Francis K. , Leung, Nelson , Muchtar, Eli , Go, Ronald S. , Gertz, Morie A. , Rajkumar, S. Vincent , Gonsalves, Wilson I.

Mayo Clinic

Cancer | November 22, 2022 | Volume: 129 | Issue: 3 | Pages: 385-392

10.1002/cncr.34545 | PMID 36413412 Get It

BackgroundSarcopenia increases with age and is associated with poor survival outcomes in patients with cancer. By using a deep learning–based segmentation approach, clinical computed tomography (CT) images of the abdomen of patients with newly diagnosed multiple myeloma (NDMM) were reviewed to determine whether the presence of sarcopenia had any prognostic value.MethodsSarcopenia was detected by accurate segmentation and measurement of the skeletal muscle components present at the level of the L3 vertebrae. These skeletal muscle measurements were further normalized by the height of the patient to obtain the skeletal muscle index for each patient to classify them as sarcopenic or not.ResultsThe study cohort consisted of 322 patients of which 67 (28%) were categorized as having high risk (HR) fluorescence in situ hybridization (FISH) cytogenetics. A total of 171 (53%) patients were sarcopenic based on their peri‐diagnosis standard‐dose CT scan. The median overall survival (OS) and 2‐year mortality rate for sarcopenic patients was 44 months and 40% compared to 90 months and 18% for those not sarcopenic, respectively (p < .0001 for both comparisons). In a multivariable model, the adverse prognostic impact of sarcopenia was independent of International Staging System stage, age, and HR FISH cytogenetics.ConclusionsSarcopenia identified by a machine learning–based convolutional neural network algorithm significantly affects OS in patients with NDMM. Future studies using this machine learning–based methodology of assessing sarcopenia in larger prospective clinical trials are required to validate these findings.
The Effects of Deep Brain Stimulation in Patients with Multiple System Atrophy
Jackson, Lauren , Klassen, Bryan T. , Hassan, Anhar , Low, Phillip A. , Badihian, Negin , Jackson, Lauren M, Singer, Wolfgang , Coon, Elizabeth A.

Mayo Clinic

Journal of Parkinson's Disease | November 22, 2022 | Volume: 12 | Issue: 8 | Pages: 2595-2600

10.3233/jpd-223504 | PMID 36442207 Get It

The course of patients with multiple system atrophy (MSA) who undergo deep brain stimulation (DBS) is unclear. In a retrospective review of 1,496 patients with MSA evaluated at our institutions from 1998–2021, 12 patients underwent DBS; 9 had a diagnosis of Parkinson’s disease at the time of surgery. Nine patients reported initial improvement in at least one symptom and 7 experienced overall worsening following DBS. All patients had at least one red flag sign or symptom suggesting atypical parkinsonism prior to surgery. Considering overall poor outcomes of DBS in MSA, we recommend careful consideration of red flags in patient selection.
Sexual Health Update in Women
Kling, Juliana M. , Saadedine, Mariam , Kapoor, Ekta , Kling, Juliana M , Faubion, Stephanie S. , Kapoor, Ekta

Mayo Clinic

Journal of Women's Health | November 22, 2022 | Volume: 32 | Issue: 1 | Pages: 10-14

10.1089/jwh.2022.0392 | PMID 36413021 Get It

Factors That Affect the Magnitude of Tibial Tubercle–Trochlear Groove Distance in Patients With Patellar Instability
Dandu, Navya , Credille, Kevin , Wang, Zachary , Cregar, William M., Trasolini, Nicholas A. , Yanke, Adam B. , Hevesi, Mario , Zavras, Athan G.

Mayo Clinic

The American Journal of Sports Medicine | November 22, 2022 | Volume: 51 | Issue: 1 | Pages: 25-31

10.1177/03635465221136535 | PMID 36412555 Get It

Background: Tibial tubercle–trochlear groove (TT-TG) distance is a risk factor for recurrent patellar dislocation and is often included in algorithmic treatment of instability. The underlying factors that determine TT-TG have yet to be clearly described in orthopaedic literature. Purpose/Hypothesis: The purpose of our study was to determine the underlying anatomic factors contributing to TT-TG distance. We hypothesized that degree of tubercle lateralization and knee rotation angle may substantially predict TT-TG. Study Design: Cross-sectional study; Level of evidence, 3. Methods: All patients evaluated for patellar instability at a single institution between 2013 and 2021 were included. Patients with previous knee osseous procedures were excluded. TT-TG and its anatomic relationship to patellofemoral measures, including dysplasia, femoral anteversion, tibial tubercle lateralization, knee rotation angle, and tibial torsion, were measured and subsequently quantified using univariate and multivariable analysis. Results: In total, 76 patients met the inclusion criteria (46 female, 30 male; mean ± SD age, 20.6 ± 8.6 years) and were evaluated. Mean TT-TG was 16.2 ± 5.4 mm. On univariate analysis, increasing knee rotation angle ( P < .01), tibial tubercle lateralization ( P = .02), and tibial torsion ( P = .01) were associated with increased TT-TG. In dysplastic cases, patients without medial hypoplasia (Dejour A or B) demonstrated significantly increased TT-TG (18.1 ± 5.4 mm) as compared with those with medial hypoplasia (Dejour C or D; TT-TG: 14.9 ± 5.2 mm; P = .02). Multivariable analysis revealed that increased knee rotation angle (+0.43-mm TT-TG per degree; P < .01) and tubercle lateralization (+0.19-mm TT-TG per percentage lateralization; P < .01) were statistically significant determinants of increased TT-TG distance. Upon accounting for these factors, tibial torsion, trochlear width, and medial hypoplasia were no longer significant components in predicting TT-TG ( P≥ .54). Of note, all patients with TT-TG ≥20 mm had tibial tubercle lateralization ≥68%, a knee rotation angle ≥5.8°, or both factors concurrently. Conclusion: TT-TG distance is most influenced by knee rotation angle and tibial tubercle lateralization.
Automated testing platform for radiotherapy treatment planning scripts
Lucido, J, Shiraishi, Satomi , Seetamsetty, Srinivas, Ellerbusch, David C., Lucido, Joseph John, Antolak, John A. , Moseley, Douglas J, Moseley, Douglas , Shiraishi, Satomi , Ellerbusch, D, Moseley, D

Mayo Clinic

Journal of Applied Clinical Medical Physics | November 22, 2022 | Volume: 24 | Issue: 1 | Pages: No page available

10.1002/acm2.13845 | PMID 36411733 Get It

AbstractRealizing the potential of user‐developed automation software interacting with a treatment planning system (TPS) requires rigorous testing to ensure patient safety and data integrity. We developed an automated test platform to allow comparison of the treatment planning database before and after the execution of a write‐enabled script interacting with a commercial TPS (Eclipse, Varian Medical Systems, Palo Alto, CA) using the vendor‐provided Eclipse Scripting Application Programming Interface (ESAPI). The C#‐application known as Write‐Enable Script Testing Engine (WESTE) serializes the treatment planning objects (Patient, Structure Set, PlanSetup) accessible through ESAPI, and then compares the serialization acquired before and after the execution of the script being tested, documenting identified differences to highlight the changes made to the treatment planning data. The first two uses of WESTE demonstrated that the testing platform could acquire and analyze the data quickly (<4 s per test case) and facilitate the clinical implementation of write‐enabled scripts.
Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
Xiao, Alexander , Yi, Dongni , Zanwar, Saurabh , Ho, Matthew , Ho, Matthew , Xiao, Alexander H , Bianchi, Giada

Mayo Clinic

Current Oncology | November 22, 2022 | Volume: 29 | Issue: 11 | Pages: 8975-9005

10.3390/curroncol29110705 | PMID 36421358 Get It

The treatment landscape of multiple myeloma (MM) has evolved considerably with the FDA-approval of at least 15 drugs over the past two decades. Together with the use of autologous stem cell transplantation, these novel therapies have resulted in significant survival benefit for patients with MM. In particular, our improved understanding of the BM and immune microenvironment has led to the development of highly effective immunotherapies that have demonstrated unprecedented response rates even in the multiple refractory disease setting. However, MM remains challenging to treat especially in a high-risk setting. A key mediator of therapeutic resistance in MM is the bone marrow (BM) microenvironment; a deeper understanding is necessary to facilitate the development of therapies that target MM in the context of the BM milieu to elicit deeper and more durable responses with the ultimate goal of long-term control or a cure of MM. In this review, we discuss our current understanding of the role the BM microenvironment plays in MM pathogenesis, with a focus on its immunosuppressive nature. We also review FDA-approved immunotherapies currently in clinical use and highlight promising immunotherapeutic approaches on the horizon.